129 related articles for article (PubMed ID: 10431018)
1. Changing perspectives on the role of corticosteroids after liver transplantation.
Lucey MR
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S58-63. PubMed ID: 10431018
[No Abstract] [Full Text] [Related]
2. [New perspectives in immunosuppression].
Sádaba B; Azanza JR; Muñoz MJ; Gil I
Nefrologia; 2005; 25(5):475-84, 486-8, 490-2. PubMed ID: 16392297
[No Abstract] [Full Text] [Related]
3. Immunosuppression: towards a logical approach in liver transplantation.
Perry I; Neuberger J
Clin Exp Immunol; 2005 Jan; 139(1):2-10. PubMed ID: 15606606
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression, cancer, and the long-term outcomes after liver transplantation: can we do better?
Abraham JM; Thompson JA
Liver Transpl; 2010 Jul; 16(7):809-11. PubMed ID: 20583078
[No Abstract] [Full Text] [Related]
5. Immunosuppression in liver transplantation.
Cattral MS; Lilly LB; Levy GA
Semin Liver Dis; 2000; 20(4):523-31. PubMed ID: 11200420
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression in pediatric liver and intestinal transplantation: a closer look at the arsenal.
Al-Hussaini A; Tredger JM; Dhawan A
J Pediatr Gastroenterol Nutr; 2005 Aug; 41(2):152-65. PubMed ID: 16056093
[No Abstract] [Full Text] [Related]
7. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
Langrehr JM; Neuhaus PJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
[No Abstract] [Full Text] [Related]
8. Immunosuppression in liver transplantation.
Post DJ; Douglas DD; Mulligan DC
Liver Transpl; 2005 Nov; 11(11):1307-14. PubMed ID: 16237688
[No Abstract] [Full Text] [Related]
9. The effect of immunosuppression on growth and development.
Balistreri WF; Bucuvalas JC; Ryckman FC
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):64-73. PubMed ID: 9346602
[No Abstract] [Full Text] [Related]
10. Immunosuppression in liver transplantation: monitoring, dose adjustment, reduction, and withdrawal.
Wall WJ; Ghent CN
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):3-10. PubMed ID: 9346595
[No Abstract] [Full Text] [Related]
11. Use of antilymphocyte induction therapy in liver transplantation.
Wall WJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
[TBL] [Abstract][Full Text] [Related]
12. Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome.
Mor E; Solomon H; Gibbs JF; Holman MJ; Goldstein RM; Husberg BS; Gonwa TA; Klintmalm GB
Semin Liver Dis; 1992 Feb; 12(1):28-40. PubMed ID: 1570549
[No Abstract] [Full Text] [Related]
13. [Rejection in liver transplantation].
Calmus Y; Bioulac-Sage P; Houssin D; Balabaud C
Gastroenterol Clin Biol; 1991; 15(8-9):629-43. PubMed ID: 1752374
[No Abstract] [Full Text] [Related]
14. Steroid immunosuppression in kidney transplantation: a passing era.
Schulak JA
J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
[No Abstract] [Full Text] [Related]
15. [Immunosuppression by individual need. Protection for the donor kidney].
MMW Fortschr Med; 2002 Jan; 144(3-4):58. PubMed ID: 11862795
[No Abstract] [Full Text] [Related]
16. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
[TBL] [Abstract][Full Text] [Related]
17. [Current possibilities and trends in biological immunosuppression in transplantation of organs and tissues. II].
Păuşescu E
Microbiol Parazitol Epidemiol (Bucur); 1973; 18(6):519-26. PubMed ID: 4597674
[No Abstract] [Full Text] [Related]
18. Present state of immunosuppressive therapy in liver transplant recipients.
Wiesner RH; Fung JJ
Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
[TBL] [Abstract][Full Text] [Related]
19. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
Yang H
Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
[TBL] [Abstract][Full Text] [Related]
20. [Implications of the immunologic response to the graft in the design of immunosuppressive treatment for liver transplantation].
de la Mata M; Barrera P; Montero JL; Fraga E; Briceño J; Pozo JC; Solórzano G
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():52-6. PubMed ID: 15195535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
